Literature DB >> 22209680

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

B Vergès1, A Avignon, F Bonnet, B Catargi, S Cattan, E Cosson, G Ducrocq, M Elbaz, A Fredenrich, P Gourdy, P Henry, O Lairez, A M Leguerrier, C Monpère, P Moulin, B Vergès-Patois, R Roussel, G Steg, P Valensi.   

Abstract

The Diabetes and Cardiovascular Disease study group of the Société francophone du diabète (SFD, French Society of Diabetes) in collaboration with the Société française de cardiologie (SFC, French Society of Cardiology) have devised a consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome (ACS); in particular, it includes the different phases of ACS [the intensive care unit (ICU) period, the post-ICU period and the short-term follow-up period after discharge, including cardiac rehabilitation] and also embraces all of the various diagnostic and therapeutic issues with a view to optimalizing the collaboration between cardiologists and diabetologists. As regards diagnosis, subjects with HbA(1c) greater or equal to 6.5% on admission may be considered diabetic while, in those with no known diabetes and HbA(1c) less than 6.5%, it is recommended that an OGTT be performed 7 to 28days after ACS. During hospitalization in the ICU, continuous insulin treatment should be initiated in all patients when admission blood glucose levels are greater or equal to 180mg/dL (10.0mmol/L) and, in those with previously known diabetes, when preprandial glucose levels are greater or equal to 140mg/dL (7.77mmol/L) during follow-up. The recommended blood glucose target is 140-180mg/dL (7.7-10mmol/L) for most patients. Following the ICU period, insulin treatment is not mandatory for every patient, and other antidiabetic treatments may be considered, with the choice of optimal treatment depending on the metabolic profile of the patient. Patients should be referred to a diabetologist before discharge from hospital in cases of unknown diabetes diagnosed during ACS hospitalization, of HbA(1c) greater or equal to 8% at the time of admission, or newly introduced insulin therapy or severe/repeated hypoglycaemia. Referral to a diabetologist after hospital discharge is recommended if diabetes is diagnosed by the OGTT, or during cardiac rehabilitation in cases of uncontrolled diabetes (HbA(1c)≥8%) or severe/repeated hypoglycaemia.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209680     DOI: 10.1016/j.diabet.2011.11.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

1.  Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications.

Authors:  Raffaele Marfella; Massimo Federici; Giuseppe Paolisso
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 2.  The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes.

Authors:  K Yu Nikolaev; A I Shevela; S V Mustafina; O D Rymar; A K Ovsyannikova; E M Zelenskaya; A Y Kovaleva; G I Lifshits
Journal:  J Pers Med       Date:  2022-05-22

3.  Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension.

Authors:  Tran Kim Son; Ngo Hoang Toan; Nguyen Thang; Huynh Le Trong Tuong; Hoang Anh Tien; Nguyen Hai Thuy; Huynh Van Minh; Paul Valensi
Journal:  Cardiovasc Diabetol       Date:  2022-05-14       Impact factor: 8.949

4.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

5.  Individuals with prediabetes identified by HbA1c undergoing coronary angiography have worse cardiometabolic profile than those identified by fasting glucose.

Authors:  Valdecira M Piveta; Celia S Bittencourt; Carolina Sv Oliveira; Pedro Saddi-Rosa; Deyse M Meira; Fernando Ma Giuffrida; André F Reis
Journal:  Diabetol Metab Syndr       Date:  2014-12-13       Impact factor: 3.320

Review 6.  Management of hyperglycemia during and in the immediate follow-up of acute coronary syndrome.

Authors:  Jamal El Ouazzani; Amine Ghalem; Ghizlane El Ouazzani; Nabila Ismaili; Noha El Ouafi
Journal:  J Saudi Heart Assoc       Date:  2017-09-01

7.  Prognostic value of admission hyperglycaemia in black Africans with acute coronary syndromes: a cross-sectional study.

Authors:  Hermann Yao; Arnaud Ekou; Thierry Niamkey; Camille Touré; Charles Guenancia; Isabelle Kouamé; Christelle Gbassi; Christophe Konin; Roland N'Guetta
Journal:  Cardiovasc J Afr       Date:  2020-09-14       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.